MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
PSNL — Personalis, Inc. Common Stock
NasdaqPersonalis, Inc. Common Stock
$16.00
-0.03(-0.19%)
- O
- 15.78
- H
- 16.10
- L
- 15.68
- V
- 3.82M
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About PSNL
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
IndustrySERVICES-MEDICAL LABORATORIES
SectorNot available
IPO DateJun 20, 2019
Employees260
Stock ExchangeNasdaq
Ticker SymbolPSNL
Websitehttps://www.personalis.com
Key Financial Statistics
| Market Cap | $1.74B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $4.96 - $18.89 |
| 52-Week Avg Volume | 2.38M |
| VWAP | $15.99 |
| Transactions | 25,505 |
| Total Recorded Bars | 1,835 days |